ATE330594T1 - Verbesserung des alkoholstoffwechsels - Google Patents

Verbesserung des alkoholstoffwechsels

Info

Publication number: ATE330594T1
Authority: AT; Austria
Prior art keywords: alcohol; glyceric acid; complexes; metabolism; nadh
Prior art date: 2002-10-14

Application number

AT03750763T

Other languages

English (en)

Inventor

Pekka Heino

Original Assignee

Remedal Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-14

Filing date

2003-10-13

Publication date

2006-07-15

2003-10-13 Application filed by Remedal Ltd filed Critical Remedal Ltd

2006-07-15 Application granted granted Critical

2006-07-15 Publication of ATE330594T1 publication Critical patent/ATE330594T1/de

Links

LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 9
230000004060 metabolic process Effects 0.000 title abstract 4
RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 abstract 5
RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 abstract 5
101710088194 Dehydrogenase Proteins 0.000 abstract 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
230000003647 oxidation Effects 0.000 abstract 3
238000007254 oxidation reaction Methods 0.000 abstract 3
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 abstract 2
238000006243 chemical reaction Methods 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
230000002708 enhancing effect Effects 0.000 abstract 2
150000002148 esters Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 abstract 1
230000002411 adverse Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000008030 elimination Effects 0.000 abstract 1
238000003379 elimination reaction Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical class C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Addiction (AREA)
Hematology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Lubricants (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT03750763T 2002-10-14 2003-10-13 Verbesserung des alkoholstoffwechsels ATE330594T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FI20021819A FI20021819A0 (fi)	2002-10-14	2002-10-14	Valmiste alkoholin metabolian tehostamiseksi

Publications (1)

Publication Number	Publication Date
ATE330594T1 true ATE330594T1 (de)	2006-07-15

Family

ID=8564745

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03750763T ATE330594T1 (de)	2002-10-14	2003-10-13	Verbesserung des alkoholstoffwechsels

Country Status (14)

Country	Link
US (1)	US7666909B2 (de)
EP (1)	EP1562576B1 (de)
JP (1)	JP2006507268A (de)
KR (1)	KR100693628B1 (de)
CN (1)	CN100459975C (de)
AT (1)	ATE330594T1 (de)
AU (1)	AU2003268987B2 (de)
CA (1)	CA2501543C (de)
DE (1)	DE60306410T2 (de)
ES (1)	ES2270074T3 (de)
FI (1)	FI20021819A0 (de)
PL (1)	PL374775A1 (de)
RU (1)	RU2343911C2 (de)
WO (1)	WO2004035040A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101166538B (zh) *	2005-05-02	2011-05-18	Cj第一制糖株式会社	用于预防和治疗酒后病的组合物
US7611739B2 (en) *	2006-01-06	2009-11-03	Amerilab Technologies, Inc.	Method of using guava extract and composition including guava extract
DE102011001768A1 (de)	2011-04-04	2012-10-04	Gunnar Frank	Präparat oder Nahrungsergänzungsmittel
US9161957B2 (en)	2012-08-03	2015-10-20	Life Well Lived, Llc	Compositions and methods for reducing blood alcohol content
EA030485B1 (ru)	2013-04-29	2018-08-31	Харша Чигурупати	Спиртные напитки с пониженной гепатотоксичностью
EP3043788B1 (de)	2013-09-13	2023-06-07	Replicon Health OY	D-glycerinsäure oder dl-glycerinsäure zur verwendung bei der behandlung von altersbedingten degenerationskrankheiten
CN115998722A (zh) *	2023-02-08	2023-04-25	内蒙古金达威药业有限公司	一种解酒保肝组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4450153A (en) *	1982-09-30	1984-05-22	Phillips Petroleum Company	Alcohol removal from blood with alcohol oxidase
JP2936233B2 (ja) *	1990-09-10	1999-08-23	有限会社野々川商事	新規美白化粧料
RU2072239C1 (ru) *	1991-01-11	1997-01-27	Институт биохимии СО РАМН	Способ коррекции метаболической зависимости от алкоголя и средство л.е.панина для его осуществления
ATE177629T1 (de) *	1991-04-10	1999-04-15	Yu Ruey J	Verwendung von 2-hydroxycarbonsäure oder deren derivaten enthaltende zusammensetzung zur linderung von wechseln nagelveränderungen
EP0617958A4 (de) *	1992-07-06	1995-09-06	Irina Alexeevna Komissarova	pharmazeutische Zusammensetzung zur Behandlung von Alkoholismus, zur Stimulierungvon Katabolismus und Magensekretion und zumSchutze gegen Strahlenbeschädigung und Cholera.
AU721728B2 (en) *	1995-04-06	2000-07-13	Baxter International Inc.	Monoisomeric glyceryl tri (chiral alkanoate) compositions and method of making same
US6117868A (en) *	1998-09-16	2000-09-12	Ed. Geistlich Sohne Ag Fur Chemische Industrie	Treatment of gastrointestinal ulcers or gastritis caused by microbial infection

2002
- 2002-10-14 FI FI20021819A patent/FI20021819A0/fi unknown
2003
- 2003-10-13 WO PCT/FI2003/000757 patent/WO2004035040A1/en not_active Ceased
- 2003-10-13 DE DE60306410T patent/DE60306410T2/de not_active Expired - Lifetime
- 2003-10-13 JP JP2004544334A patent/JP2006507268A/ja active Pending
- 2003-10-13 AU AU2003268987A patent/AU2003268987B2/en not_active Ceased
- 2003-10-13 PL PL03374775A patent/PL374775A1/xx unknown
- 2003-10-13 ES ES03750763T patent/ES2270074T3/es not_active Expired - Lifetime
- 2003-10-13 CA CA002501543A patent/CA2501543C/en not_active Expired - Fee Related
- 2003-10-13 AT AT03750763T patent/ATE330594T1/de not_active IP Right Cessation
- 2003-10-13 RU RU2005113980/15A patent/RU2343911C2/ru not_active IP Right Cessation
- 2003-10-13 KR KR1020057006373A patent/KR100693628B1/ko not_active Expired - Fee Related
- 2003-10-13 CN CNB2003801014124A patent/CN100459975C/zh not_active Expired - Fee Related
- 2003-10-13 EP EP03750763A patent/EP1562576B1/de not_active Expired - Lifetime
2005
- 2005-04-13 US US11/105,022 patent/US7666909B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2003268987B2 (en)	2005-11-03
CA2501543C (en)	2008-08-19
US7666909B2 (en)	2010-02-23
PL374775A1 (en)	2005-10-31
EP1562576A1 (de)	2005-08-17
CN100459975C (zh)	2009-02-11
JP2006507268A (ja)	2006-03-02
CN1705476A (zh)	2005-12-07
US20050182135A1 (en)	2005-08-18
CA2501543A1 (en)	2004-04-29
EP1562576B1 (de)	2006-06-21
DE60306410T2 (de)	2007-06-14
KR100693628B1 (ko)	2007-03-14
WO2004035040A1 (en)	2004-04-29
KR20050050671A (ko)	2005-05-31
DE60306410D1 (de)	2006-08-03
RU2343911C2 (ru)	2009-01-20
AU2003268987A1 (en)	2004-05-04
RU2005113980A (ru)	2006-01-20
ES2270074T3 (es)	2007-04-01
FI20021819A0 (fi)	2002-10-14

Legal Events

Date

Code

Title

Description

2007-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1562576

Country of ref document: EP

2010-07-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
CN1049334C (zh)	2000-02-16	脂肪酸药剂的新用途
TWI314452B (en)	2009-09-11	Amino acid composition and supplemental solution
NZ597193A (en)	2014-01-31	Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
NZ627238A (en)	2016-02-26	Stable pharmaceutical composition comprising ethyl eicosapentaenoate
CN1635864A (zh)	2005-07-06	寡糖醛糖酸及在局部表面上的应用
WO2003072111A3 (en)	2004-03-18	Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression
WO2006086108A3 (en)	2007-01-11	Use of inhibitors of soluble epoxide hydrolase to synergize activity of cox and 5-lox inhibitors
ATE330594T1 (de)	2006-07-15	Verbesserung des alkoholstoffwechsels
WO2007047194A3 (en)	2007-12-13	Methods for treating mitf-related disorders
WO2006000867B1 (en)	2006-05-18	Compositions for topical treatment
US20150374660A1 (en)	2015-12-31	Ascorbate Esters of Omega-3 Fatty Acids and Their Formulations and Uses
EA200401052A1 (ru)	2005-02-24	Стимуляция cpt-1 как средство уменьшения веса
CN113197884A (zh)	2021-08-03	α-酮丁酸在制备预防和/或治疗非酒精性脂肪肝的药物中的应用
JPH07285881A (ja)	1995-10-31	アルコール代謝促進剤
Kasemset et al.	1984	Regulation of Mn-SOD activity in the mouse heart: Glucose effect
FR2531632A1 (fr)	1984-02-17	Produits pharmaceutiques avec action cytostatique, a base d'esters d'acides gras
JP2005132766A (ja)	2005-05-26	光動力学的癌治療薬
EP1875906A3 (de)	2008-02-27	Therapeutische Verwendung von Yessotoxinen als Wachstumshemmer für humane Tumorzellen
US20080200539A1 (en)	2008-08-21	Topical antifungal treatment
Khan-Siddiqui	2018	Lysine-carnitine conversion in rat and man
RU2005104207A (ru)	2006-07-27	Способ лечения больных ишемической болезнью сердца
CN1610558A (zh)	2005-04-27	用于治疗钙化的含阿司匹林的透皮吸收药物组合物
KR890000399A (ko)	1989-03-14	(e)-2-(p-플루오로펜에틸)-3-플루오로알릴아민
JP2012067055A (ja)	2012-04-05	セルレニンを含有する経皮吸収促進剤
FR2897534A1 (fr)	2007-08-24	Utilisation du tesaglitazar pour la preparation d'une composition pharmaceutique destinee au traitement des affections dermatologiques